Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001144204-08-067039

10% owner bought 25,000 shares at $1.17 ($29,290)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Trinad Capital Master Fund Ltd. 10% owner 2008-11-25 Purchase +25,000 $1.17 $29,290 2,338,170 D: show line 1 in the form
Open-market purchases · 25,000 sh · avg $1.17 · $29,290
Loading xslF345X03/v133712_ex.xml…